Compare $CLYM vs $IRWD | Chartloom

Compare

$CLYM vs $IRWD

Climb Bio Inc · Ironwood Pharmaceuticals Inc

CLYM

Climb Bio Inc

IRWD

Ironwood Pharmaceuticals Inc

Compare $CLYM vs $IRWD

Comparing Climb Bio Inc and Ironwood Pharmaceuticals Inc

CLYMClimb Bio Inc

IRWDIronwood Pharmaceuticals Inc

CLYMClimb Bio Inc

Market cap

$630M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

193.3%

52W performance

511.1%

FCF yield

-8.4%

IRWDIronwood Pharmaceuticals Inc

Market cap

$629M

P/E (TTM)

4.92x

Forward P/E (NTM)

2.96x

Forward P/S (NTM)

1.30x

Rev growth (TTM)

26.2%

YTD performance

-10.5%

52W performance

141.8%

FCF yield

29.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CLYM

IRWD

Detailed metrics comparison

CLYM

Climb Bio Inc

IRWD

Ironwood Pharmaceuticals Inc

Market Cap

CLYM$630M

IRWD$629M

Enterprise Value

CLYM$586M

IRWD$935M

Price

CLYM$11.00

IRWD$3.82

P/E Ratio

CLYMN/A

IRWD4.92x

P/S Ratio

CLYM0.00x

IRWD1.62x

EV/Sales

CLYM0.00x

IRWD2.40x

EV/EBITDA

CLYM0.00x

IRWD3.93x

P/B Ratio

CLYM2.62x

IRWD0.85x

P/FCF Ratio

CLYMN/A

IRWD3.39x

EV/FCF

CLYM-11.04x

IRWD5.04x

PEG Ratio

CLYMN/A

IRWDN/A

Forward P/E (NTM)

CLYMN/A

IRWD2.96x

Forward P/S (NTM)

CLYMN/A

IRWD1.30x

Revenue (TTM)

CLYM$0

IRWD$389M

Revenue Growth (YoY)

CLYMN/A

IRWD26.2%

Forward Rev Growth

CLYM27.3%

IRWD6.4%

Gross Margin (TTM)

CLYM0.0%

IRWD100.0%

Operating Margin (TTM)

CLYM0.0%

IRWD60.2%

EBITDA Margin (TTM)

CLYM0.0%

IRWD61.1%

Net Margin (TTM)

CLYM0.0%

IRWD33.4%

FCF Margin (TTM)

CLYMN/A

IRWD47.7%

Net Income (TTM)

CLYM$-58M

IRWD$130M

FCF (TTM)

CLYM$-53M

IRWD$186M

EPS (TTM)

CLYM-$0.76

IRWD$0.78

ROE (TTM)

CLYM-3179.0%

IRWD29.3%

ROA (TTM)

CLYM-3079.0%

IRWD34.3%

ROIC (TTM)

CLYM-3179.0%

IRWD17.9%

Cash

CLYM$44M

IRWD$79M

Debt

CLYM$0

IRWD$385M

Net Cash/Debt

CLYM$44M

IRWD$-306M

Current Ratio (TTM)

CLYM31.45x

IRWD6.06x

Quick Ratio (TTM)

CLYM30.86x

IRWD5.84x

Debt/Equity (TTM)

CLYM0.00x

IRWD0.56x

Debt/Assets (TTM)

CLYM0.0%

IRWD0.0%

Interest Coverage (TTM)

CLYMN/A

IRWDN/A

Net Debt/EBITDA (TTM)

CLYM0.00x

IRWD0.00x

Beta

CLYM-0.01

IRWD0.22

52W Performance

CLYM511.1%

IRWD141.8%

YTD Performance

CLYM193.3%

IRWD-10.5%

% from 52W High

CLYM-40.0%

IRWD-33.9%

% from 52W Low

CLYM572.8%

IRWD170.9%

Asset Turnover (TTM)

CLYM0.00x

IRWD1.03x

FCF Yield (TTM)

CLYM-8.4%

IRWD29.5%

Earnings Yield (TTM)

CLYM-9.1%

IRWD20.7%

Dividend Yield (TTM)

CLYMN/A

IRWDN/A

Rule of 40

CLYM0.0

IRWD73.8

EV/GP/RG

CLYMN/A

IRWD0.10

Ticker research

View CLYM research View IRWD research

Metric	CLYM Climb Bio Inc	IRWD Ironwood Pharmaceuticals Inc
Market & Valuation
Market Cap	$630M	$629M
Enterprise Value	$586M	$935M
Price	$11.00	$3.82
P/E Ratio	N/A	4.92x
P/S Ratio	0.00x	1.62x
EV/Sales	0.00x	2.40x
EV/EBITDA	0.00x	3.93x
P/B Ratio	2.62x	0.85x
P/FCF Ratio	N/A	3.39x
EV/FCF	-11.04x	5.04x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	2.96x
Forward P/S (NTM)	N/A	1.30x
Revenue & Growth
Revenue (TTM)	$0	$389M
Revenue Growth (YoY)	N/A	26.2%
Forward Rev Growth	27.3%	6.4%
Profitability
Gross Margin (TTM)	0.0%	100.0%
Operating Margin (TTM)	0.0%	60.2%
EBITDA Margin (TTM)	0.0%	61.1%
Net Margin (TTM)	0.0%	33.4%
FCF Margin (TTM)	N/A	47.7%
Net Income (TTM)	$-58M	$130M
FCF (TTM)	$-53M	$186M
EPS (TTM)	-$0.76	$0.78
ROE (TTM)	-3179.0%	29.3%
ROA (TTM)	-3079.0%	34.3%
ROIC (TTM)	-3179.0%	17.9%
Financial Health
Cash	$44M	$79M
Debt	$0	$385M
Net Cash/Debt	$44M	$-306M
Current Ratio (TTM)	31.45x	6.06x
Quick Ratio (TTM)	30.86x	5.84x
Debt/Equity (TTM)	0.00x	0.56x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.01	0.22
52W Performance	511.1%	141.8%
YTD Performance	193.3%	-10.5%
% from 52W High	-40.0%	-33.9%
% from 52W Low	572.8%	170.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	1.03x
FCF Yield (TTM)	-8.4%	29.5%
Earnings Yield (TTM)	-9.1%	20.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	73.8
EV/GP/RG	N/A	0.10
Ticker research	View CLYM research	View IRWD research

Valuation

P/E Ratio

IRWD

4.92x

P/S Ratio

CLYM

0.00x

IRWD

1.62x

EV/FCF

CLYM

-11.04x

IRWD

5.04x

Growth & revenue

Revenue Growth TTM

IRWD

26.2%

Forward Revenue Growth

CLYM

27.3%

IRWD

6.4%

Profitability & performance

Gross Margin

IRWD

100.0%

CLYM

0.0%

ROE

IRWD

29.3%

CLYM

-3179.0%

FCF Yield %

IRWD

29.5%

CLYM

-8.4%

52-Week Performance

CLYM

511.1%

IRWD

141.8%

Detailed metrics comparison

CLYM

Climb Bio Inc

IRWD

Ironwood Pharmaceuticals Inc

Market Cap

CLYM$630M

IRWD$629M

Enterprise Value

CLYM$586M

IRWD$935M

Price

CLYM$11.00

IRWD$3.82

P/E Ratio

CLYMN/A

IRWD4.92x

P/S Ratio

CLYM0.00x

IRWD1.62x

EV/Sales

CLYM0.00x

IRWD2.40x

EV/EBITDA

CLYM0.00x

IRWD3.93x

P/B Ratio

CLYM2.62x

IRWD0.85x

P/FCF Ratio

CLYMN/A

IRWD3.39x

EV/FCF

CLYM-11.04x

IRWD5.04x

PEG Ratio

CLYMN/A

IRWDN/A

Forward P/E (NTM)

CLYMN/A

IRWD2.96x

Forward P/S (NTM)

CLYMN/A

IRWD1.30x

Revenue (TTM)

CLYM$0

IRWD$389M

Revenue Growth (YoY)

CLYMN/A

IRWD26.2%

Forward Rev Growth

CLYM27.3%

IRWD6.4%

Gross Margin (TTM)

CLYM0.0%

IRWD100.0%

Operating Margin (TTM)

CLYM0.0%

IRWD60.2%

EBITDA Margin (TTM)

CLYM0.0%

IRWD61.1%

Net Margin (TTM)

CLYM0.0%

IRWD33.4%

FCF Margin (TTM)

CLYMN/A

IRWD47.7%

Net Income (TTM)

CLYM$-58M

IRWD$130M

FCF (TTM)

CLYM$-53M

IRWD$186M

EPS (TTM)

CLYM-$0.76

IRWD$0.78

ROE (TTM)

CLYM-3179.0%

IRWD29.3%

ROA (TTM)

CLYM-3079.0%

IRWD34.3%

ROIC (TTM)

CLYM-3179.0%

IRWD17.9%

Cash

CLYM$44M

IRWD$79M

Debt

CLYM$0

IRWD$385M

Net Cash/Debt

CLYM$44M

IRWD$-306M

Current Ratio (TTM)

CLYM31.45x

IRWD6.06x

Quick Ratio (TTM)

CLYM30.86x

IRWD5.84x

Debt/Equity (TTM)

CLYM0.00x

IRWD0.56x

Debt/Assets (TTM)

CLYM0.0%

IRWD0.0%

Interest Coverage (TTM)

CLYMN/A

IRWDN/A

Net Debt/EBITDA (TTM)

CLYM0.00x

IRWD0.00x

Beta

CLYM-0.01

IRWD0.22

52W Performance

CLYM511.1%

IRWD141.8%

YTD Performance

CLYM193.3%

IRWD-10.5%

% from 52W High

CLYM-40.0%

IRWD-33.9%

% from 52W Low

CLYM572.8%

IRWD170.9%

Asset Turnover (TTM)

CLYM0.00x

IRWD1.03x

FCF Yield (TTM)

CLYM-8.4%

IRWD29.5%

Earnings Yield (TTM)

CLYM-9.1%

IRWD20.7%

Dividend Yield (TTM)

CLYMN/A

IRWDN/A

Rule of 40

CLYM0.0

IRWD73.8

EV/GP/RG

CLYMN/A

IRWD0.10

Ticker research

View CLYM research View IRWD research

Metric	CLYM Climb Bio Inc	IRWD Ironwood Pharmaceuticals Inc
Market & Valuation
Market Cap	$630M	$629M
Enterprise Value	$586M	$935M
Price	$11.00	$3.82
P/E Ratio	N/A	4.92x
P/S Ratio	0.00x	1.62x
EV/Sales	0.00x	2.40x
EV/EBITDA	0.00x	3.93x
P/B Ratio	2.62x	0.85x
P/FCF Ratio	N/A	3.39x
EV/FCF	-11.04x	5.04x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	2.96x
Forward P/S (NTM)	N/A	1.30x
Revenue & Growth
Revenue (TTM)	$0	$389M
Revenue Growth (YoY)	N/A	26.2%
Forward Rev Growth	27.3%	6.4%
Profitability
Gross Margin (TTM)	0.0%	100.0%
Operating Margin (TTM)	0.0%	60.2%
EBITDA Margin (TTM)	0.0%	61.1%
Net Margin (TTM)	0.0%	33.4%
FCF Margin (TTM)	N/A	47.7%
Net Income (TTM)	$-58M	$130M
FCF (TTM)	$-53M	$186M
EPS (TTM)	-$0.76	$0.78
ROE (TTM)	-3179.0%	29.3%
ROA (TTM)	-3079.0%	34.3%
ROIC (TTM)	-3179.0%	17.9%
Financial Health
Cash	$44M	$79M
Debt	$0	$385M
Net Cash/Debt	$44M	$-306M
Current Ratio (TTM)	31.45x	6.06x
Quick Ratio (TTM)	30.86x	5.84x
Debt/Equity (TTM)	0.00x	0.56x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.01	0.22
52W Performance	511.1%	141.8%
YTD Performance	193.3%	-10.5%
% from 52W High	-40.0%	-33.9%
% from 52W Low	572.8%	170.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	1.03x
FCF Yield (TTM)	-8.4%	29.5%
Earnings Yield (TTM)	-9.1%	20.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	73.8
EV/GP/RG	N/A	0.10
Ticker research	View CLYM research	View IRWD research